Regulation of airway inflammation by Siglec-8 and Siglec-9 sialoglycan ligand expression

Research output: Contribution to journalReview article

10 Citations (Scopus)

Abstract

Purpose of review Inflammatory cells involved in the allergic response, including eosinophils, mast cells, basophils, and neutrophils, express sialoglycan-binding proteins such as Siglec-8 and Siglec-9, which inhibit cell function and survival. The purpose of this review is to briefly discuss the biology of these siglecs and their ligands and consider their potential impact in pathology and treatment of chronic rhinosinusitis (CRS). Recent findings Recent studies demonstrate the presence of ligands for Siglec-8 and Siglec-9 in sinonasal tissue from patients with CRS as well as healthy patients, suggesting that the immunoregulatory functions of siglecs may be triggered in sinus tissue in health and disease. Summary Ligands for Siglec-8 and Siglec-9 may regulate the function of eosinophils, mast cells, neutrophils, and other cells in sinus mucosa. Therapeutic strategies that activate the anti-inflammatory effects of siglecs may dampen inflammation and disease in CRS patients.

Original languageEnglish (US)
Pages (from-to)24-30
Number of pages7
JournalCurrent Opinion in Allergy and Clinical Immunology
Volume16
Issue number1
DOIs
StatePublished - Jan 1 2016

Fingerprint

Sialic Acid Binding Immunoglobulin-like Lectins
Ligands
Inflammation
Eosinophils
Mast Cells
Neutrophils
Basophils
Cell Survival
Carrier Proteins
Mucous Membrane
Chronic Disease
Anti-Inflammatory Agents

Keywords

  • Chronic rhinosinusitis
  • Eosinophil
  • Glycan
  • Mast cell
  • Siglec

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

@article{ab54d61bf206484a9c98412a070c8a44,
title = "Regulation of airway inflammation by Siglec-8 and Siglec-9 sialoglycan ligand expression",
abstract = "Purpose of review Inflammatory cells involved in the allergic response, including eosinophils, mast cells, basophils, and neutrophils, express sialoglycan-binding proteins such as Siglec-8 and Siglec-9, which inhibit cell function and survival. The purpose of this review is to briefly discuss the biology of these siglecs and their ligands and consider their potential impact in pathology and treatment of chronic rhinosinusitis (CRS). Recent findings Recent studies demonstrate the presence of ligands for Siglec-8 and Siglec-9 in sinonasal tissue from patients with CRS as well as healthy patients, suggesting that the immunoregulatory functions of siglecs may be triggered in sinus tissue in health and disease. Summary Ligands for Siglec-8 and Siglec-9 may regulate the function of eosinophils, mast cells, neutrophils, and other cells in sinus mucosa. Therapeutic strategies that activate the anti-inflammatory effects of siglecs may dampen inflammation and disease in CRS patients.",
keywords = "Chronic rhinosinusitis, Eosinophil, Glycan, Mast cell, Siglec",
author = "Schleimer, {Robert P} and Schnaar, {Ronald L.} and Bochner, {Bruce Scott}",
year = "2016",
month = "1",
day = "1",
doi = "10.1097/ACI.0000000000000234",
language = "English (US)",
volume = "16",
pages = "24--30",
journal = "Current Opinion in Allergy and Clinical Immunology",
issn = "1528-4050",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

Regulation of airway inflammation by Siglec-8 and Siglec-9 sialoglycan ligand expression. / Schleimer, Robert P; Schnaar, Ronald L.; Bochner, Bruce Scott.

In: Current Opinion in Allergy and Clinical Immunology, Vol. 16, No. 1, 01.01.2016, p. 24-30.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Regulation of airway inflammation by Siglec-8 and Siglec-9 sialoglycan ligand expression

AU - Schleimer, Robert P

AU - Schnaar, Ronald L.

AU - Bochner, Bruce Scott

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Purpose of review Inflammatory cells involved in the allergic response, including eosinophils, mast cells, basophils, and neutrophils, express sialoglycan-binding proteins such as Siglec-8 and Siglec-9, which inhibit cell function and survival. The purpose of this review is to briefly discuss the biology of these siglecs and their ligands and consider their potential impact in pathology and treatment of chronic rhinosinusitis (CRS). Recent findings Recent studies demonstrate the presence of ligands for Siglec-8 and Siglec-9 in sinonasal tissue from patients with CRS as well as healthy patients, suggesting that the immunoregulatory functions of siglecs may be triggered in sinus tissue in health and disease. Summary Ligands for Siglec-8 and Siglec-9 may regulate the function of eosinophils, mast cells, neutrophils, and other cells in sinus mucosa. Therapeutic strategies that activate the anti-inflammatory effects of siglecs may dampen inflammation and disease in CRS patients.

AB - Purpose of review Inflammatory cells involved in the allergic response, including eosinophils, mast cells, basophils, and neutrophils, express sialoglycan-binding proteins such as Siglec-8 and Siglec-9, which inhibit cell function and survival. The purpose of this review is to briefly discuss the biology of these siglecs and their ligands and consider their potential impact in pathology and treatment of chronic rhinosinusitis (CRS). Recent findings Recent studies demonstrate the presence of ligands for Siglec-8 and Siglec-9 in sinonasal tissue from patients with CRS as well as healthy patients, suggesting that the immunoregulatory functions of siglecs may be triggered in sinus tissue in health and disease. Summary Ligands for Siglec-8 and Siglec-9 may regulate the function of eosinophils, mast cells, neutrophils, and other cells in sinus mucosa. Therapeutic strategies that activate the anti-inflammatory effects of siglecs may dampen inflammation and disease in CRS patients.

KW - Chronic rhinosinusitis

KW - Eosinophil

KW - Glycan

KW - Mast cell

KW - Siglec

UR - http://www.scopus.com/inward/record.url?scp=84952865216&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84952865216&partnerID=8YFLogxK

U2 - 10.1097/ACI.0000000000000234

DO - 10.1097/ACI.0000000000000234

M3 - Review article

VL - 16

SP - 24

EP - 30

JO - Current Opinion in Allergy and Clinical Immunology

JF - Current Opinion in Allergy and Clinical Immunology

SN - 1528-4050

IS - 1

ER -